RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Imaging"
DOI: 10.1186/s40644-019-0271-z
Abstract: BackgroundTo evaluate the objective response rate (ORR) at 2 months of treatment with regorafenib according to RECIST 1.1, Choi, and modified Choi (mChoi) criteria in patients with metastatic colorectal cancer (mCRC).MethodsBaseline and 2-month contrast-enhanced computed-tomography (CECT)… read more here.
Keywords: choi criteria; recist choi; cancer; choi ... See more keywords